15,800/Strip Wegovy 0.5mg FlexTouch is a prescription medicine that belongs to a class called GLP-1 receptor agonists
It potentially can cause pancreatitis
Accidentally injecting the wrong medication could have serious consequences
These agents are FDA-approved primarily for the management of type 2 diabetes mellitus and, for specific products (Wegovy, Saxenda, Zepbound), for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity
A March 2025 study by researchers at the University of Pennsylvania found 85% people on GLP-1s scored worse on a Waterless Empirical Taste Test, which involved touching flavored plastic strips to their tongues, compared to people not on the drugs
Ozempic is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes, administered as a once-weekly subcutaneous injection